A Brief Sketch of Gene Therapy Vectors and Delivery Methods
Gene therapy is the technique of introducing a healthy gene into a defective cell and help improve a disease condition. The field holds much promise as it seeks to cure …
Read MoreThe Next Generation Biotech Media
Gene therapy is the technique of introducing a healthy gene into a defective cell and help improve a disease condition. The field holds much promise as it seeks to cure …
Read MoreIn August 2020, GSK’s antibody-drug conjugate, Blenrep, became the first FDA-approved anti-BCMA therapy for highly refractory Multiple Myeloma (MM). The agency has now granted authorization for a second drug targeting …
Read MoreGene therapy is a hot commodity in the biopharma business, attracting profitable investments and expensive M&A transactions in recent years. Moreover, the frequent reports of research breakthroughs and clinical trial …
Read MoreGeneseeq Technology Inc. is a company that provides cutting-edge, next-generation sequencing (NGS) technology to advance precision oncology. The company has two headquarters, one in Toronto, Canada, and another in Nanjing, …
Read MoreCelularity Inc. is a clinical-stage biotech specializing in developing off-the-shelf, allogeneic therapies derived from the postpartum human placenta. On March 18th, the New Jersey-based biotech announced that the FDA had granted …
Read MoreMultiple sclerosis (MS) affects 2.3 million people globally, with 1 million in the US alone. It occurs when our immune system attacks the myelin sheath, a fatty substance that insulates …
Read MoreWhat if we could enhance the potential of Natural Killer (NK) cell therapies which offers key advantages over CAR T-cell therapies? Acepodia, a privately held US-Taiwan biotech, develops next-generation, off-the-shelf …
Read MoreMarch 15th, 2021 – When shares of GenMark Diagnostics surged to a record high in early February, Bloomberg reported that several prospective buyers were approaching the California-based company. Today, those …
Read MoreJapan initiated its COVID-19 vaccination program as early as mid-February with the Pfizer/BioNTech vaccine. However, it has only managed to administer just 46,500 doses in three weeks, which is about …
Read MoreAlzheimer’s disease (AD) is an age-related neurodegenerative disorder that accounts for 60%-80% of all dementia cases. The disease is characterized by two major neuropathological hallmarks — amyloid plaques composed of …
Read More